Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2003
12/18/2003WO2001078648A3 6-methylnicotinamide derivatives as antiviral agents
12/18/2003US20030232998 A 4-imidazolines carboxyl acids or esters as a potent non-steroidal antiinflammatory agents, microbiocides, bactericides, antitumor agents; chemical intermediates
12/18/2003US20030232990 For therapy of arteriosclerosis and dyslipidaemias
12/18/2003US20030232986 Inhibitors of caspases
12/18/2003US20030232985 For therapy of Alzheimer's disease and Down's Syndrome
12/18/2003US20030232873 Tetrahydrocarbazol derivatives as ligands for G-protein-coupled receptors (GPCR)
12/18/2003US20030232870 Multi-substituted imidazolines and method of use thereof
12/18/2003US20030232869 N3 alkylated benzimidazole derivatives as MEK inhibitors
12/18/2003US20030232865 1,4-Benzofused urea compounds useful in treating cytokine mediated diseases
12/18/2003US20030232864 Novel Compounds and compositions as protease inhibitors
12/18/2003US20030232863 Cathepsin cysteine protease inhibitors
12/18/2003US20030232861 Reacting magnesium with lower alcohol to produce magnesium alkoxide, adding omeprazole, then flash-evaporating solvent; for treatment of gastrointestinal inflammatory diseases
12/18/2003US20030232860 Medicine comprising dicyanopyridine derivative
12/18/2003US20030232854 Such as 3-methyl-5-(2-chloro-6-fluorophenyl)-4-isoxazole-carboxylic acid ethyl ester for inhibiting multidrug resistance protein (MRP1)
12/18/2003US20030232849 N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/18/2003US20030232848 Pyrazole compositions
12/18/2003US20030232842 Nitrogen compounds such as methyl 4-(2-chloro-4-fluorophenyl) -2-(3,5-difluoropyridin-2-yl)-6-(4-morpholinylmethyl)-1,4-dihydropyrimidine -5-carboxylate, with mixtures of lamivudine and interferons, used as viricides; hepatitis
12/18/2003US20030232840 Oxazolidinone photoaffinity probes
12/18/2003US20030232837 17-Beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
12/18/2003US20030232836 Secondary amides such as 2-(4-(2- methoxyphenyl)-1-piperazinyl )-N-(3-methylphenyl)acetamide, used for prophylaxis of impotency
12/18/2003US20030232831 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
12/18/2003US20030232826 Amidino and guanidino peptidyl compounds
12/18/2003US20030232822 Ht3 receptor antagonists
12/18/2003US20030232816 Benzimidazole derivatives
12/18/2003US20030232814 Novel compounds and their use
12/18/2003US20030232808 Sulfonyl derivatives
12/18/2003US20030232807 Dietetic agents
12/18/2003US20030232804 Glycinamides as factor Xa inhibitors
12/18/2003US20030232801 Identification of compounds for the treatment or prevention of proliferative diseases
12/18/2003US20030232790 Dihydro-2h-napthalene-1-one inhibitors of ras farnesyl transferase
12/18/2003US20030232789 Salicylamides as serine protease and factor xa inhibitors
12/18/2003US20030232053 Administering to treat rheumatoid arthritis, cancer, restenosis
12/18/2003US20030232008 Oxazolidinone photoaffinity probes
12/18/2003US20030229950 Hair dyes
12/18/2003US20030229949 Hair dyes; fast coloration of keratin fibers
12/18/2003CA2497609A1 Non-peptidic brs-3 agonists
12/18/2003CA2488798A1 Substituted pyrrolines as kinase inhibitors
12/18/2003CA2488602A1 Substituted pyrrolines as kinase inhibitors
12/18/2003CA2488406A1 Yellow anionic disazo dyes
12/18/2003CA2488402A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003CA2488193A1 Inhibitors of the gpib -vwf interaction, their preparation and use
12/18/2003CA2486491A1 4-(aryl or heteroaryl)-2-butylamine derivatives and their use as glucocorticoid ligans
12/18/2003CA2485725A1 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
12/17/2003EP1371648A1 Phthalazine derivatives phosphodiesterase 4 inhibitors
12/17/2003EP1371647A2 Pyridine-3-carboxylic acid derivatives and their use as intermediates
12/17/2003EP1371646A1 Aryl-substituted alicyclic compound and medical composition comprising the same
12/17/2003EP1371376A1 Antipruritics
12/17/2003EP1371361A1 Novel suppository form comprising an acid-labile active compound
12/17/2003EP1370682A2 Assay for identifying inhibitors of the rna dependent rna polymerase (ns5b) of hcv
12/17/2003EP1370558A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
12/17/2003EP1370557A1 Benzimidazole anti-inflammatory compounds
12/17/2003EP1370556A1 Metalloproteinase inhibitors
12/17/2003EP1370553A2 Rho-kinase inhibitors
12/17/2003EP1370552A2 Rho-kinase inhibitors
12/17/2003EP1370551A2 New compounds useful as antibacterial agents
12/17/2003EP1370550A1 Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same
12/17/2003EP1370549A1 Methods for the preparation of mirtazapine intermediates
12/17/2003EP1370538A1 Metalloproteinase inhibitors
12/17/2003EP1370537A1 Metalloproteinase inhibitors
12/17/2003EP1370536A1 Metalloproteinase inhibitors
12/17/2003EP1370535A1 Metalloproteinase inhibitors
12/17/2003EP1370534A1 Metalloproteinase inhibitors
12/17/2003EP1370533A2 Imidiazole derivatives and their use as agonists selective at alpha 2b or 2b/2c adrenergic receptors
12/17/2003EP1370531A1 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors
12/17/2003EP1370528A1 Mch antagonists and their use in the treatment of obesity
12/17/2003EP1370262A1 New use of iloperidone
12/17/2003EP1370261A2 New use
12/17/2003EP1370258A2 Peptide deformylase inhibitors
12/17/2003EP1370250A2 Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis
12/17/2003EP1370211A2 Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP1189889B1 Compositions and methods for inhibiting cell death
12/17/2003EP1109805B1 Inhibitors of bacterial nad synthetase
12/17/2003EP1098878B1 Bispiperidines as antithrombotic agents
12/17/2003EP0934276B1 Anthranilic acid derivatives as multi drug resistance modulators
12/17/2003CN1462269A Fused azepine drivatives and their use as antidiuretic agents
12/17/2003CN1461748A Synthesis process of jiatisasin
12/17/2003CN1131228C Benzo (5,6) cyclohepta (1,2-6) pyridine derivs. for inhibition of farnesy-protein transferase
12/17/2003CN1131216C Condensed 1,2-indene dihydride and its salt for medicine its preparation method and application
12/17/2003CN1131212C Phenyl-and pyridinyl derivatives
12/17/2003CN1131211C Heteraryl diazacy cloa lkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/16/2003US6664398 Derivatives of erythromycin, their preparation process and their use as medicaments
12/16/2003US6664397 Administering to subject effective dose of (+)-mefloquine or pharmaceutically acceptable salt thereof substantially free of (-)-enantiomer; reduced side effects
12/16/2003US6664395 Benzotriazole compoundsn are the potent inhibitors of MAP kinases, preferably p38 kinase. They are useful for treating inflammation, osteoarthritis, rheumatoid arthritis, cancer, reperfusion, ischemia
12/16/2003US6664277 Prenylation inhibitors containing dimethylcyclobutane and methods of their synthesis and use
12/16/2003US6664276 Antiulcer agent
12/16/2003US6664275 C10 heterosubstituted acetate taxanes
12/16/2003US6664273 Having at least cyanobenzyl and amidobenzyl substituents; obesity, metabolic disorders, eating disorders such as hyperphagia and diabetes
12/16/2003US6664272 Such as 1,5-Bis-(2, 4-difluorophenyl)penta-1,4-diene-3 -one; administering to inhibit tissue factor and vascular endothelial growth factor (VEGF) production in cancerous tissue
12/16/2003US6664269 Isoquinolinone derivatives
12/16/2003US6664256 Interleukin- 1 beta inhibitors
12/16/2003US6664255 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
12/16/2003US6664253 Neurokinin antagonists
12/16/2003US6664249 Bicyclic vasopressin agonists
12/16/2003US6664248 Well tolerated by animals, fish and plants
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003US6664025 Ethylenically unsaturated monomer capable of free radical addition polymerizatio catalysis; binder, photoinitiator and cyanopyidone sensitizer; metallocene and onium coninitiators
12/16/2003CA2178272C Antiviral monocyclic polyamines
12/16/2003CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals
12/11/2003WO2003102588A2 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
1 ... 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 ... 1080